Concepedia

Bala Attili

BA

Statistics

Publications

8

Citations

221

H-Index

8

Active since

2016

Affiliations

KU Leuven(Current)

VIB-KU Leuven Center for Brain & Disease Research

Addenbrooke's Hospital

University of Cambridge

AstraZeneca (United Kingdom)

Bala Attili is an author at KU Leuven specializing in pharmacology, neuroprotection, and neuroimmunology.

ORCID

Top concepts

Publications per year

2016–2024

8

Publications

8

TSPO Versus P2X7 as a Target for Neuroinflammation: An In Vitro and In Vivo Study

Donatienne Van Weehaeghe, Evelien Van Schoor, Joke De Vocht et al. · Journal of Nuclear Medicine · 2019 · 58 citations · Full text

, , +16

Synthesis and preclinical evaluation of [ 11 C]MA-PB-1 for in vivo imaging of brain monoacylglycerol lipase (MAGL)

Muneer Ahamed, Bala Attili, Daisy van Veghel et al. · European Journal of Medicinal Chemistry · 2017 · 31 citations · Full text

, , +6

Preclinical evaluation of [<sup>18</sup>F]MA3: a CB<sub>2</sub> receptor agonist radiotracer for PET

Bala Attili, Sofie Celen, Muneer Ahamed et al. · British Journal of Pharmacology · 2018 · 26 citations · Full text

Evaluation of [<sup>11</sup>C]NMS-E973 as a PET tracer for <i>in vivo</i> visualisation of HSP90

Koen Vermeulen, Evelyne Naus, Muneer Ahamed et al. · Theranostics · 2019 · 25 citations · Full text

Preclinical Evaluation of AZD6422, an Armored Chimeric Antigen Receptor T Cell Targeting CLDN18.2 in Gastric, Pancreatic, and Esophageal Cancers

Allison M. Barrett, Zachary T. Britton, Rosa A. Carrasco et al. · Clinical Cancer Research · 2024 · 25 citations · Full text

Rows per page

1–5 of 8